InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 3 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding InMed Pharmaceuticals Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 15 | 1 | 5 | −9 |
| Shares | 1.14M | 125 | 48.9K | −1.09M (−95.7%) |
| Value | $266.0K | $0 | $226.7K | −$39.3K (−14.8%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Danske Bank A/S | 1 | $5 | 0.00% |
Sold out (10)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Citadel Advisors LLC | 56,666 | $13.3K |
| Renaissance Technologies LLC | 50,296 | $11.9K |
| HRT Financial LP | 38,369 | $8.00K |
| Virtu Financial LLC | 28,415 | $7.00K |
| Baader Bank INC | 22,611 | $3.84K |
| Bank of America Corp | 100 | $24 |
| Advisor Group Holdings, Inc. | 27 | $5 |
| Global Retirement Partners, LLC | 6 | $1 |
| Royal Bank of Canada | 24 | $0 |
| Gables Capital Management Inc. | 1 | $0 |
Not filed for Q4 2024 yet (1)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Banque Cantonale Vaudoise | 125 | $0 |